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The CRISPR/Cas technology enables targeted genome editing and the rapid generation of transgenic animal models for the
study of human genetic disorders. Here we describe an autosomal recessive human disease in two unrelated families char-
acterized by a split-foot defect, nail abnormalities of the hands, and hearing loss, due to mutations disrupting the SAM
domain of the protein kinase ZAK. ZAK is a member of the MAPKKK family with no known role in limb development.
We show that Zak is expressed in the developing limbs and that a CRISPR/Cas-mediated knockout of the two Zak isoforms
is embryonically lethal in mice. In contrast, a deletion of the SAMdomain induces a complex hindlimb defect associated with
down-regulation of Trp63, a known split-hand/split-foot malformation disease gene. Our results identify ZAK as a key play-
er in mammalian limb patterning and demonstrate the rapid utility of CRISPR/Cas genome editing to assign causality to
human mutations in the mouse in <10 wk.
[Supplemental material is available for this article.]
Split-hand/split-foot malformation (SHFM) is a limb anomaly
characterized by median clefts with missing or malformed central
rays (Elliott et al. 2005). SHFM is clinically and genetically hetero-
geneous and represents a paradigmatic genetic disorder displaying
different modes of inheritance, variable expressivity, and in-
complete penetrance (Birnbaum et al. 2012; Klopocki et al.
2012). Submicroscopic duplications at 10q24 and 17p13.3, TP63
mutations, and deletions of exonic enhancers in DYNC1I1 repre-
sent major SHFM-causing mechanisms (Ianakiev et al. 2000; de
Mollerat et al. 2003; Birnbaum et al. 2012; Klopocki et al. 2012).
Mutations in other genes, includingWNT10B in an autosomal re-
cessive form, have been reported. However, in up to two thirds of
affected individuals, the causative mutation remains unknown
(Ugur and Tolun 2008; Tayebi et al. 2014). One of the key challeng-
es in rare Mendelian disorders is to identify additional disease al-
leles in unrelated families. CRISPR/Cas genome editing can now
be used to create a large number of new alleles in themousewithin
a few weeks by creating specific mutations and deletions in a gene
of interest (Wang et al. 2013; Kraft et al. 2015). Here we report on
the combination of whole-exome sequencing in patients with
CRISPR/Cas genome editing inmice to identify and validate a nov-
el disease-causing gene and to assign an unexpected role to the
protein kinase ZAK in mammalian limb development.
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Results
Identification of ZAK mutations in split-foot malformation
with mesoaxial polydactyly
We studied an autosomal recessive disorder characterized by a
split-foot phenotype, nail abnormalities of the hands, and hearing
impairment. In a multiplex consanguineous Pakistani family with
four affected individuals (family F1) (Fig. 1; Supplemental Figs. 1,
2), autozygosity mapping following single-nucleotide polymor-
phism (SNP) array genotyping identified a disease locus on
Chromosome 2q31 with a maximum LOD score of 3.5 (Fig. 2A;
Supplemental Fig. 1A). The 9.1-Mb linkage region does not con-
tain any known gene that is mutated in limb malformations.
After performing exome sequencing of one affected individual
(F1-VI:3) and filtering for rare potentially damaging variants, we
detected two homozygousmissense variants in the linkage region:
c.1247T > A (p.Phe416Tyr) in ZNF385B and c.1103T >G
(p.Phe368Cys) in ZAK (Fig. 2B; Supplemental Fig. 1B). Both vari-
ants cosegregated with the disease, were predicted to be damaging,
and were absent or very rare in controls (Supplemental Table 1).
As neither of the two genes had a known function in limb develop-
ment, we performed whole-mount in situ hybridization (ISH) on
Figure 1. Split-footmalformationwithmesoaxial polydactyly (SFMMP) in two families. (A) Pedigree of family F1. Black symbols indicate individuals with a
split-foot phenotype and/or hearing loss. (+) c.1103T reference allele of ZAK; (−) c.1103T > G (p.Phe368Cys) mutation of ZAK. Autozygosity mapping was
performed with DNA from individuals designated with an asterisk; and exome sequencing was performed with DNA from individual VI:3, designated with
an arrowhead. (B) Pedigree of family F2. IV:2 is affected by the split-foot phenotype. (+) Reference allele; (−) genomic deletion of exons 12–16 of ZAK.
(C ) Pictures of the feet of affected individuals from family F1 showing no split foot in V:2, bilateral split-foot malformation in VI:3 and VI:4, and unilateral
split-foot malformation in VI:1. (D) Hands and feet of the affected child in family F2. The nail anomaly is boxed. (E) Radiographs of the feet of individual VI:4
in family 1 showing bilateral split-foot malformation, syndactyly between the first and rudimentary second toes, duplication of the left proximal phalanx of
the second toe corresponding to mesoaxial polydactyly (arrowhead), Y-shaped appearance of the right metatarsal bone II due to synostosis between the
horizontally placed remnant of the proximal phalanx II and the hypoplastic metatarsal II, and hypoplastic and misshaped phalangeal bones of toes III to V
with fusions of some interphalangeal joints. In addition to split-foot malformationwithmissing third toe, the radiograph of the left foot of individual F2-IV:2
shows cutaneous syndactyly between the first and second toes and hypoplasia of the distal phalanx of the first ray and of themiddle and distal phalanges of
the second toe. A second rudimentary phalangeal bone of toe II is present (arrowhead). There is hypoplasia of middle and distal phalanges of toes IV and V,
as well as syndactyly between these toes. (F ) Clinical pictures of individual F1-IV:4 and individual F2-IV:2 showing a duplication of the nail bed on digit IV of
both hands.
Spielmann et al.
184 Genome Research
www.genome.org
 Cold Spring Harbor Laboratory Press on June 12, 2020 - Published by genome.cshlp.orgDownloaded from 
mouse embryos for Znf385b and Zak to prioritize these candidate
genes for further studies. While Znf385b was mainly expressed in
the developing brain (Supplemental Fig. 3), Zak was expressed in
the heart and the developing limbs (Fig. 3), making it a plausible
candidate gene for limb defects. Furthermore in an RNA-seq data
set of human embryonic hindlimbs published by Cotney et al.
(2013), ZAK was shown to be expressed in human limbs, while
ZNF585B expression was not detected. The zinc finger protein
385B (ZNF385B, formerly known as ZNF533) is also expressed in
the developing brain (http://www.brain-map.org/), lungs, and
ovaries (http://www.proteinatlas.org/), but its function is currently
unknown.Overlapping deletions ofZNF385Bhave been identified
in patients withmental retardation, high palate, andmicrognathia
(Mencarelli et al. 2007; Monfort et al. 2008). Therefore ZNF385B
was suggested to be a candidate gene for mental retardation. We
next sequenced ZAK in 106 unrelated patients representing the
broad clinical SHFM spectrum. In an affected boy from Tunisia
(F2-IV:2) (Fig. 1B,D,F),weusedPCR,array-CGH,andqPCRtodetect
a homozygous intragenic deletion of ZAK (Fig. 2B; Supplemental
Fig. 4A,B) that was heterozygous in his unaffected first-cousin par-
ents (Supplemental Fig. 4B). The boy presented with a very similar
split-foot phenotype, including distal duplication of digit II and
Figure 2. Identification of homozygous ZAK mutations in SFMMP. (A) Representation of genome-wide homozygosity in family F1 following SNP array
genotyping with 250k arrays. Homozygosity scores with respect to themaximum LOD score of 3.5 are plotted against the physical position genome-wide.
The linkage region on Chromosome 2 is indicated by the red peak; it is 9.1 Mb in size and delimited by recombinant markers rs836624 and rs6433931. (B)
Schematic representation of ZAKwith themissensemutation and the intragenic deletion shown in red. The ZAK protein contains a kinase domain, as well as
a leucine zipper (LZ) and a sterile alpha motif (SAM) domain. Multiple protein sequence alignment; the Phe368Cys mutation site is boxed in red.
ZAK mutations in limb defects in humans and mice
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unilateral syndactyly I/II and IV/V (Fig. 1C–F). Thehandswere nor-
mal, but the nails of both digits IV showed a duplication of the nail
bed (Fig. 1F). The patient had normal newborn hearing screening,
and at the age of 2 yr, the psychomotor and language development
was normal. As shown by sequencing of a junction PCR fragment,
this 14.7-kb deletion removed exons 12–16 of ZAK (Supplemental
Fig. 4C); it was absent from in-house (n = >600) andpublicCNVda-
tabases (Firth et al. 2009; MacDonald et al. 2014).
As typically observed in SHFM, there was marked phenotypic
variability in both affected families with foot defects in affected in-
dividuals ranging from bilateral to unilateral foot involvement to
no split foot in one individual (F1-V:2) (Fig. 1C). Individuals F1-
VI:4 and F2-VI:2 showed partial duplication of digit II in combina-
tionwith syndactyly I/II (Fig. 1C–E). The patients also had duplica-
tions of the nail bed on the hands (Fig. 1F). In addition to limb
defects, all patients in family 1 had bilateral sensorineural hearing
impairment (Supplemental Fig. 2), consistent with Zak expression
in hair cells of the mouse cochlea (Francis et al. 2013). We refer to
this distinct phenotype as “split-foot malformation with mesoax-
ial polydactyly” (SFMMP).
ZAK is a member of the MAPKKK family that is involved in
the control of cell growth and differentiation, the regulation of cy-
toskeletal changes, and gene expression (Yang 2003; Cheng et al.
2009). No role had been assigned to ZAK in vertebrate limb devel-
opment, but knockdown of its Xenopus laevis ortholog mltk was
previously shown to result in loss of craniofacial cartilage (Gotoh
et al. 2001; Suzuki et al. 2012). ZAK was shown to be a direct target
of TP63 binding, and a functional link of both proteins was sug-
gested; ZAK has also been shown to suppress the JNK pathway
(Yang et al. 2006; Wang et al. 2014a). The ZAK gene encodes two
isoforms, both containing an N-terminal protein kinase domain
followed by a leucine zipper (LZ). Notably, the missense alteration
and the intragenic deletion both affect the SAM domain, which is
only present in the longer ZAK-α isoform. While the deletion is
predicted to remove the complete SAMdomain, Phe368Cys affects
a highly conserved residue (Fig. 2B).
Generation and analysis of Zak−/− mice using CRISPR/Cas
genome editing in mice
The recent development of the CRISPR/Cas technology has led
to a wider use of genome editing and opens new possibilities
to create mutations and structural variations within weeks in
model systems for the investigation of rare Mendelian disorders
(Wang et al. 2013). We therefore aimed to study the role of mu-
tations in Zak in transgenic mice using CRISPR/Cas genome ed-
iting. To create a complete knockout of both Zak isoforms, we
designed one single guide RNA (sgRNA) in exon 2 and transfect-
ed mouse embryonic stem cells (ESCs) with the CRISPR con-
struct. We created homozygous frameshift mutations in exon
2 (Supplemental Fig. 5A) and performed diploid ESC aggregation
to produce highly chimeric animals. The CRISPR/Cas-mediated
inactivation of Zak resulted in fully penetrant lethality at E9.5
due to severe cardiac edema and growth retardation (Supple-
mental Fig. 5B). No viable homozygous mice were obtained
from two independent clones. In contrast, heterozygous mice
were morphologically indistinguishable from their wild-type
littermates.
Since both the missense mutation and the intragenic dele-
tion affect the SAM domain of ZAK-α, we hypothesized that muta-
tions exclusively in the SAM domain might be responsible for the
split-foot phenotype. We therefore aimed to genocopy the intra-
genic deletion of family 2 by specifically deleting the SAM domain
using an adapted CRISPR/Cas protocol for the introduction of
structural variants (Kraft et al. 2015; Lupianez et al. 2015). We
transfected two CRISPR/Cas sgRNAs flanking the deletion and cre-
ated ESCs with homozygous deletions of the 12-kb fragment. The
deletion was predicted to be in frame, and expression analysis
confirmed normal Zak mRNA levels in the embryonic limbs
(Supplemental Fig. 6A). No predicted off-target mutation was
found via Sanger sequencing (Supplemental Fig. 6B). In highly
(>95%) chimeric animals generated from two independent homo-
zygous clones, we observed a spectrumof unilateral complex hind-
limb duplication phenotypes with low penetrance (four out of
64 animals) (Fig. 4A–D). In one mouse at E18.5, one supernumer-
ary hindlimbwith normal polarity was connected to an imperfect-
ly duplicated pelvic girdle (Fig. 4A). The duplicated hindlimb
showed a shortened femur, fibula, and tibia, and a normal sized
foot. The forelimbs were normal. At later stages, variable splitting
of the distal skeleton of the hindlimbs was observed. One mouse
showed a partial duplication of the right hindlimb and pelvic
structures (Fig. 4B; Supplemental Video 1). While the foot was
completely duplicated, the fibula and tibia were partially duplicat-
ed (Fig. 4C), and the femur shaft was split showing duplications of
the distal parts (Fig. 4D). Twomice showed polydactyly of the feet,
representing a minimal version of a distal duplication defect
(Supplemental Fig. 7). Themutant mice did not show any obvious
ear abnormalities, and the Preyer’s reflex as screening to identify
profound sensorineural hearing loss did not show differences be-
tween mutants, heterozygous littermates, or wild-type mice (Jero
et al. 2001).
To identify regulators or interaction partners of ZAK, we per-
formedwhole-mount ISHs and expression analysis for selected key
limb development genes. ISH in homozygous Zak−/− embryos re-
vealed normal staining patterns for Fgf8, Shh, and Trp63 at E11.5
(Supplemental Fig. 8). We noted that themutantmice looked sim-
ilar to mice treated in utero with retinoic acid, showing lower limb
duplications andhindlimboligodactyly (Niederreither et al. 1996).
Treatment of limb bud cells with retinoic acid results in a down-
regulation of Trp63 (Wang et al. 2014b). We therefore performed
quantitative reverse transcription–PCR (qRT-PCR) for Trp63 in
Zak-mutant limb tissue (Yang et al. 2006) and detected a 60%
decreaseofTrp63expression inhomozygousversuswild-typehind-
limbs (Fig. 4E).
Figure 3. Expression of Zak in mouse embryos. In situ hybridization us-
ing a probe for Zak on mouse embryos at the indicated embryonic days.
(Top) Whole embryos; (bottom) magnifications of the forelimb (FL).
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Functional analysis of the Phe368Cys missense substitution
affecting the SAM domain of ZAK
To finally understand how the Phe368Cys substitution affects the
structure of the ZAK SAM domain, we generated a 3D model (Fig.
5A; Harada et al. 2008; Kelley and Sternberg 2009). The model pre-
dicts that Phe368 is located in the hydrophobic core of the pro-
tein. Mutation to Cys might therefore disrupt the hydrophobic
core and lead to SAM domain instability. To test this hypothesis,
we purified both the wild-type and mutant ZAK SAM domain
and assessed the secondary structure of each using circular dichro-
ism (CD). The CD spectrum of Phe368Cys showed a ∼30% loss of
alpha-helicity compared with the wild-type (Fig. 5B). Moreover,
thermal unfolding experiments showed a cooperative, albeit irre-
versible, unfolding transition for the wild-type ZAK SAM domain,
while the mutant showed a complete loss of cooperative unfold-
ing transition (Supplemental Fig. 9). These results indicate that
the Phe368Cys mutation strongly destabilizes the ZAK SAM
domain.
ZAK self-associates in vivo and this may be mediated by the
SAM domain and/or the LZ (Liu et al. 2000). Size exclusion chro-
matography–multi-angle light scattering (SEC-MALS) analysis of
a purified ZAK SAM domain and a LZ-SAM fusion revealed that
the SAMdomain alone ismonomeric while the LZ drives dimeriza-
tion (Fig. 5C). The Phe368Cys mutant caused retarded migration
on a native gel assay (Knight et al. 2011), indicating that it is aggre-
gation prone (Fig. 5D), consistent with protein unfolding and
pathogenicity of the mutation.
Discussion
Our data show that ZAK-α has a role in limb development and that
the deletion of its SAM domain is associated with down-regulation
of Trp63 in the limb bud. Mutations affecting the expression of
TRP63 are associated with a wide spectrum of limb phenotypes:
While the knockout of Trp63 results in severe truncation of both
limbs, knock-in of an SHFM mutation Arg279His causes a com-
plete reduction of hindlimbs and milder reduction of forelimbs
(Yang et al. 1999; Vanbokhoven et al. 2011). In contrast, treatment
of mice with retinoic acid was shown to cause lower limb duplica-
tions, polydactyly, and oligodactyly, at least in part due to down-
regulation of Trp63 (Niederreither et al. 1996; Wang et al. 2014b).
Thereforewe speculate that mutations in ZAK causing a down-reg-
ulation of Trp63 in the hindlimb give rise to a wide spectrum of
lower limb phenotypes with reduced penetrance and variable ex-
pressivity. Genetically unresolved cases of SHFM and other com-
plex limb defects may be caused by mutations in other members
of the ZAK pathway. However, much more experimental work is
needed to investigate a potential functional link between TP63
and ZAK.
In this study, we exemplarily show that the CRISPR/Cas9
system can be used to efficiently reengineer human variants in
Figure 4. Limb defects in CRISPR/Cas mice with a deletion of the ZAK SAM domain. (A) At E18.5, one supernumerary hindlimb with normal polarity was
connected to an imperfectly duplicated pelvic girdle. The duplicated hindlimb showed a shortened femur, fibula, and tibia and normal-sized digits. (B) A 5-
wk-old mouse showed a partial duplication of the right hindlimb and pelvic structures. (C) The foot was completely duplicated (blue) and connected by a
common digit V with a distal duplication (red). The fibula and tibia were only partially duplicated. (D) The right femur shaft was split, and the distal and
proximal parts (red) were duplicated. The left femur appeared normal (blue). (E) Expression analysis of Zakdel/del homozygous mutant (MT) hindlimbs at
E11.5 showed a 60% decrease of Trp63 expression compared with wild-type (WT) hindlimbs. Error bars, SD.
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mice with the purpose to test their pathogenicity. This approach
holds the promise to contribute to a paradigmatic shift in the in-
vestigation ofMendelian disorders. In fact, formany years the con-
firmation and functional validation of causative mutations in
previously unreported disease genes has relied on conducting
time-consuming experiments directed at recapitulating key fea-
tures of the disease in cell systems or animal models. The genera-
tion of such animal models, however, was expensive and time-
consuming (Ruf et al. 2011; Sternberg and Doudna 2015). By tak-
ing advantage of the CRISPR/Cas9 genome editing technology to
induce site-specific genomic double-strand breaks in the mouse
that are repaired by the nonhomologous end-joining (NHEJ) path-
way, we show that several mouse models for a novel human dis-
ease can be generated in <10 wk (Lieber 2010; Kraft et al. 2015;
Lupianez et al. 2015). The CRISPR/Cas9 system in combination
with a template sequence can also be used for the introduction
of precise genetic modifications through an alternative homolo-
gy-directed repair (HDR) pathway (Chu et al. 2015). This will be ex-
tremely useful in the future to investigate the pathogenicity of rare
missense alleles that might occur only in single families. Thus, be-
yond the identification of ZAK as a key player in mammalian limb
patterning, our results demonstrate the utility of CRISPR/Cas9 ge-
nome editing to assign causality to human mutations in the
mouse.
In conclusion, we describe a syndrome characterized by a
split-foot phenotype, nail abnormalities, and hearing loss due to
isoform-specific mutations of ZAK. Our results identify ZAK-α as
a key player in limb patterning. Furthermore we demonstrate
that CRISPR/Cas genome editing can be used for the fast and effi-
cient creation of new associated alleles in the mouse to study the
pathogenicity of mutations and deletions in a gene of interest in
Mendelian disorders.
Methods
Subjects and ethics approval
The study was performed with the approval of the University of
Ulm ethics committee and the institutional review board (IRB) of
the Balochistan University of Information Technology, Engineer-
ing, and Management Sciences (BUITEMS). Patients were enrolled
with written informed consent for participation in the study. The
clinical evaluation included medical history interviews, a physical
examination, radiographs of hands and feet, and review ofmedical
Figure 5. Functional effects of ZAK SAM domainmissense mutation. (A) Phyremodel of the ZAK SAM domain based on the structure of the SAM domain
of DGKD (30% identity, PDB ID 3BQ7). Phe368 resides in the hydrophobic core of the SAM domain and is shown as spheres highlighted in red. (B) Circular
dichroism spectra of wild-type ZAK-SAM and the Phe368Cys mutant. The altered spectrum of ZAK-SAM Phe368Cys correlates with a loss of alpha-helicity.
(C ) Purified ZAK-SAM and ZAK-LZ-SAM were assessed by SEC-MALS. The SAM domain alone is monomeric with an observed molecular weight (MW) of
10.2 kDa (predicted MW= 8.9 kDa). The LZ-SAM construct has an observed MW of 32.3 kDa, corresponding to a homogenous population of dimer (pre-
dicted dimer MW= 29.6 kDa). (D) negGFP fusions of wild-type and Phe368Cys mutants of ZAK-SAM and ZAK-LZ-SAM assessed by native gel electropho-
resis. In this assay, described previously (Liu et al. 2000), proteins are fused to a highly negative green fluorescent protein (negGFP). The negative charges
on negGFP cause reliablemigration toward the cathode in a native gel, and the relativemobility reflects oligomerization.Monomeric SAMdomainsmigrate
as discrete bands and with higher mobility than polymeric SAM domains, which migrate slower and with a smeared character. negGFP fusions of a mo-
nomeric SAM (ANKS6) and a polymeric SAM (DGKD) are shown as controls. ZAK-SAM appears monomeric, and addition of the LZ causes a significant gel
shift. The Phe368Cys (F368C) substitution in the ZAK SAM domain causes a retarded migration, indicating protein aggregation.
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records. Blood sampleswere obtained fromeach participating indi-
vidual, and DNA was extracted by standard procedures.
SNP-array genotyping and autozygosity mapping
We performed a genome-wide linkage analysis with autozygosity
mapping by using Affymetrix genome-wide human SNP 6.0 arrays
and genomic DNA samples from five members of family 1, name-
ly, the four affected individuals V:2, VI:1, VI:3, and VI:4, as well as
the unaffected individual VI:2. Autozygosity mapping was per-
formed as previously described (Borck et al. 2011).
Exome sequencing
Exome sequencing was performed in individual VI:3 in family 1.
Briefly, genomic DNAwas enriched for exonic and adjacent splice
site sequences with the SeqCap EZ human exome library v2.0 kit,
and libraries were run on an Illumina HiSeq 2000 sequencer via a
paired-end 100-bp protocol (Hussain et al. 2013). For data analysis,
the Cologne Center for Genomics (CCG) Varbank pipeline v2.6
and user interface was used (Kawalia et al. 2015). Primary data
were filtered according to signal purity by the Illumina realtime
analysis (RTA) software v1.8. Subsequently, the readsweremapped
to the humangenome reference buildGRCh37/hg19 (http://www.
genome.ucsc.edu/) using the BWA-SW alignment algorithm.
Mean coverage was 100× in the exome, and 95.6% and 86.4% of
target bases were covered more than 10× and 30×, respectively.
Further annotation and filtering for high-quality rare variants
(MAF < 0.1%) with a predicted impact on protein sequence or
splicing was performed as previously described (Borck et al.
2015).We also filtered against an inhouse database containing var-
iants from 511 exomes from individuals with epilepsy to exclude
pipeline-related artifacts.
Sanger sequencing
In family 1, validation and cosegregation analyses were performed
by Sanger sequencing on an ABI 3730 DNA analyzer with BigDye
chemistry v3.1. In family 2, the complete coding region of ZAK
(NM_016653.2), including splice sites, was sequenced (for primer
sequences and positions, see Supplemental Table 2).
Microarray-based comparative genomic hybridization
Microarray-based comparative genomic hybridization (arrayCGH)
for family 2was carried out using awhole-genome 1-M oligonucle-
otide array (Agilent); 1 M arrays were analyzed by feature ex-
traction v9.5.3.1 and CGH analytics v3.4.40 software or
cytogenomics v2.5.8.11, respectively (Agilent). Analysis settings
were as follows: aberration algorithm, ADM-2; threshold, 6.0; win-
dow size, 0.2 Mb; filter, 5probes; log2ratio = 0.29. The genomic
profile was visualized by the SignalMap software (SignalMap
v1.9.0.03, NimbleGen Systems).
Quantitative real-time PCR (qPCR)
qPCR was performed as previously described (Kraft et al. 2015) us-
ing genomic DNA of the index patients and further family mem-
bers to confirm the deletions and to show segregation with the
phenotype (for primer sequences, see Supplemental Table 3).
Breakpoint analysis
The exact determination of the deletion size was done by break-
point spanning PCR following the qPCR analyses and sequencing
of the junction fragment (primer sequences and positions in
Supplemental Table 2). For the sequencing of the PCR products,
the BigDye v3.1 (Applied Biosystems) sequencing kit was used.
PCR products were analyzed by capillary automat ABI3730 (Ap-
plied Biosystems). The sequencing results were processed by
DNA-STAR software (DNA-Star).
Cloning and mutagenesis
negGFP-fusions of hZAK (UniProt:Q9NYL2) encompassing the
SAM domain (residues 333–410; “ZAK-SAM”) and including the
upstream LZ region (residues 286–410; “ZAK-LZ-SAM”) were gen-
erated by cloning into a negGFP vector described previously
(Knight et al. 2011). Hexahistidine small ubiquitin-like modifier
(SUMO) tagged constructs were generated by cloning the above se-
quences into a pHis-SUMOvector (Senturia et al. 2010). Site-direct-
ed mutagenesis was performed using the Quickchange method
(Agilent). All plasmid sequences were verified by DNA sequencing
(Genewiz).
negGFP native gel assay
negGFP-human-ZAK fusions were transformed into ARI814 cells
and expressed, harvested, and lysed as described previously
(Knight et al. 2011; Leettola et al. 2014). Expression levels were de-
termined by fluorescence intensity, and based on fluorescence,
equal amounts of protein were loaded on a 20% RunBlue 12-well
native gel (Expedeon). Gels were run at 90 V for 16 h at 4°C and
visualized on a Bio-Rad molecular imager FX pro-plus using an ex-
citationwavelength of 488 nm and an emissionwavelength of 510
nm. In an attempt to identify ZAK hetero–SAM interactions,
negGFP-ZAK-SAM was mixed in a 1:1 ratio based on fluorescence,
and negGFP-ZAK-LZ-SAM was mixed in a 3:1 ratio based on fluo-
rescence with 54 other negGFP fusions of hSAM domains. Mixes
were allowed to equilibrate for 3 h at 4°C before running on native
gels. Neither screen detected any hetero interactions.
Protein expression and purification
pHis-SUMO constructs (ZAK-SAM, ZAK-SAM F368C, and ZAK-LZ-
SAM) were transformed into Rosetta(DE3) pLysS cells (Novagen),
and 4 L of culture was grown to an OD600 of 0.6, at which point
cells were induced with 1 mM isopropyl β-D-galactopyranoside
and grown for an additional 16 h at 18°C. Harvested cells were
lysed, and pHis-SUMO tagged proteins were purified using Ni-
NTA (Qiagen) as described previously (Leettola et al. 2014).
Proteins were dialyzed into 20 mM NaHPO4 (pH 8), 0.5 M NaCl,
and 2 mM βME and digested with the His6-tagged catalytic
domain of SUMO protease 1 (ULP1) at a 50:1 protein:protease mo-
lar ratio for 16 h at 4°C (Malakhov et al. 2004). The cleaved His6-
SUMO tag and ULP1 protease were removed by subtractive Ni-
NTA. Proteins were further purified by dialysis into either 20 mM
Tris (pH 7.5; ZAK-SAM and ZAK-SAM F368C) or 20 mM Tris (pH
7.0; ZAK-LZ-SAM), 50 mM NaCl, 2 mM βME and bound to a
HiTrap Q HP column (GE). Elution was achieved using a shallow
gradient of NaCl (0.05–1 M across 20 column volumes) dissolved
in either 20mMTris (pH 7.0 or pH 7.5) or 2mM βME. The proteins
eluted between 0.3 and 0.4 M NaCl.
Circular dichroism
Spectra were collected for protein samples at 0.2 mg/mL in 10 mM
Tris (pH 7.5), 75mMNaCl, 1 mMDTT at 25°C using a 1-mmpath-
length cuvette on a JASCO J-715 CD spectrophotometer equipped
with a Peltier temperature control. Spectra were analyzed for sec-
ondary structure content using the Neural Network algorithm
available in SoftSec (Softwood). Thermal melts were performed
by monitoring the change in CD signal at 222 nm across a
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temperature range of 25°C–80°C, with ramping of 1°C per minute.
Wild-type ZAK-SAM and ZAK-SAM F368C thermal denaturation
was not reversible.
SEC-MALS
Purified ZAK-SAM and ZAK-LZ-SAMwere dialyzed into 20mMTris
(pH 7.5), 0.15 M NaCl, 2 mM TCEP. One hundred twenty microli-
ters of protein at 10 mg/mL was loaded onto aWTC-030S5 analyt-
ical size-exclusion column (Wyatt Technology) equilibrated in
20mMTris (pH 7.5), 0.15MNaCl, 2 mM TCEP using an AKTA pu-
rifier (GE) with a flow rate of 0.7 mL/min and analyzed using a
miniDAWN TREOS (Wyatt Technology). Eluted protein peaks
were analyzed for calculatedmolecular weight andmonodispersity
using ASTRA software (Wyatt Technology).
CRISPR sgRNAs selection and cloning
SgRNAs were designed to induce point mutations or flanking the
regions to rearrange. We used the http://crispr.mit.edu/ platform
to obtain candidate sgRNA sequences with little off-targets speci-
ficity. Complementary strands were annealed, phosphorylated,
and cloned into the BbsI site of pX459 or pX330 CRISPR/Cas vec-
tor (for CRISPR sgRNAs sequences and positions, see Supplemental
Table 3).
ESC culture and transfection
We seeded 300,000 G4 cells (129xC57BL/6 F1 hybrid ESCs) on
CD1 feeders and transfected them with 8 μg of each CRISPR con-
struct using FuGENE technology (Promega). When the construct
originated from the pX330 vector, cells were cotransfected with
a puromycine-resistant plasmid. PX459, in contrast, already con-
tains a puromycine-resistant cassette. After 24 h, cells were split
and transferred onto DR4 puro-resistant feeders and selected
with puromycine for 2 d. Clones were then grown for 5–6 more
days, picked, and transferred into 96-well plates on CD-1 feeders.
After 2 d of culture, plates were split in triplicates, two for freezing
and one for growth and DNAharvesting. Positive clones identified
by PCR or Sanger sequencing were thawed and grown on CD-1
feeders until they reached an average of 4 million cells. Three vials
were frozen, and DNA was harvested from the rest of the cells to
confirm genotyping. PCR-based genotyping and qPCR were per-
formed as previously described (Kraft et al. 2015).
To create a complete knockout of both Zak isoforms, we de-
signed one sgRNA in exon 2. We detected compound and homo-
zygous mutations in 83 clones (out of 96) and selected two
clones with homozygous frameshift mutations in exon 2 for dip-
loid ESC aggregation. To genocopy the intragenic deletion of fam-
ily 2, an adapted CRISPR/Cas protocol for the introduction of
structural variants was used (Kraft et al. 2015; Lupianez et al.
2015).We designed two sgRNAs located in the introns centromeric
and telomeric to exons 12 and 16 of Zak. We then cotransfected
the two sgRNAs in mouse ESCs to induce double-strand breaks at
the desired positions.We detected 17 heterozygous and two clones
(out of 288) with a homozygous deletion of the 12-kb fragment
(Supplemental Fig. 10).
Mouse aggregation
A frozen ESC vial was seeded onCD-1 feeders, and cells were grown
for 2 d. Mice were generated by diploid or tetraploid ESC aggrega-
tion (Artus and Hadjantonakis 2011). All animal procedures were
in accordance with institutional, state, and government regula-
tions (Berlin: LAGeSo).
ISH and skeletal preparations
ISH for Zak, Fgf8, Trp63, and Shh was carried out on wild-type em-
bryos (C57BL/6J) and mutant embryos at embryonic stages E11.5.
Skeletal preparations and alizarin red staining of E18.5 wild-type
and mutant embryos were performed as previously described
(Albrecht et al. 2002).
Data access
ZAK mutation data from this study have been submitted to the
NCBI ClinVar database (http://www.ncbi.nlm.nih.gov/clinvar/)
under accession number SCV000256897. Array-CGH data from
this study have been submitted to the DECIPHER database (http://
decipher.sanger.ac.uk) under patient ID: 321328. Sequencing data
from this studyhave been submitted to the EuropeanGenome-phe-
nome Archive (EGA, http://www.ebi.ac.uk/ega/), which is hosted at
the EBI, under accession number EGAS00001001633.
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